SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Atrion Corp. – ‘10-K’ for 12/31/21 – ‘EX-23’

On:  Friday, 2/25/22, at 4:31pm ET   ·   For:  12/31/21   ·   Accession #:  1654954-22-2094   ·   File #:  1-32982

Previous ‘10-K’:  ‘10-K’ on 3/1/21 for 12/31/20   ·   Next:  ‘10-K’ on 2/27/23 for 12/31/22   ·   Latest:  ‘10-K’ on 2/29/24 for 12/31/23   ·   20 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/25/22  Atrion Corp.                      10-K       12/31/21   73:5.3M                                   Blueprint/FA

Annual Report   —   Form 10-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    824K 
 2: EX-4.A      Instrument Defining the Rights of Security Holders  HTML     32K 
 3: EX-13.1     Annual or Quarterly Report to Security Holders      HTML     23K 
 4: EX-21       Subsidiaries List                                   HTML     20K 
 5: EX-23       Consent of Expert or Counsel                        HTML     18K 
 6: EX-31.1     Certification -- §302 - SOA'02                      HTML     23K 
 7: EX-31.2     Certification -- §302 - SOA'02                      HTML     23K 
 8: EX-32.1     Certification -- §906 - SOA'02                      HTML     19K 
 9: EX-32.2     Certification -- §906 - SOA'02                      HTML     19K 
15: R1          Cover                                               HTML     87K 
16: R2          Consolidated Balance Sheets                         HTML    139K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     34K 
18: R4          Consolidated Statements of Income                   HTML     97K 
19: R5          Consolidated Statements of Changes in Stockholders  HTML     67K 
                Equity                                                           
20: R6          Consolidated Statements of Cash Flows               HTML    105K 
21: R7          Summary of Significant Accounting Policies          HTML    109K 
22: R8          Investments                                         HTML     65K 
23: R9          Patents and Licenses                                HTML     31K 
24: R10         Line of Credit                                      HTML     23K 
25: R11         Income Taxes                                        HTML     80K 
26: R12         Stockholders Equity                                 HTML     27K 
27: R13         Income Per Share                                    HTML     39K 
28: R14         Stockbased Compensation                             HTML     62K 
29: R15         Industry Segment and Geographic Information         HTML     25K 
30: R16         Employee Retirement and Benefit Plans               HTML     24K 
31: R17         Commitment and Contingencies                        HTML     24K 
32: R18         Summary of Significant Accounting Policies          HTML    151K 
                (Policies)                                                       
33: R19         Summary of Significant Accounting Policies          HTML     91K 
                (Tables)                                                         
34: R20         Investments (Tables)                                HTML     62K 
35: R21         Patents and Licenses (Tables)                       HTML     31K 
36: R22         Income Taxes (Tables)                               HTML     81K 
37: R23         Income Per Share (Tables)                           HTML     38K 
38: R24         Stockbased Compensation (Tables)                    HTML     59K 
39: R25         Summary of Significant Accounting Policies          HTML     58K 
                (Details)                                                        
40: R26         Summary of Significant Accounting Policies          HTML     28K 
                (Details 1)                                                      
41: R27         Summary of Significant Accounting Policies          HTML     36K 
                (Details 2)                                                      
42: R28         Summary of Significant Accounting Policies          HTML     30K 
                (Details 3)                                                      
43: R29         Summary of Significant Accounting Policies          HTML     34K 
                (Details 4)                                                      
44: R30         Summary of Significant Accounting Policies          HTML     34K 
                (Details 5)                                                      
45: R31         Summary of Significant Accounting Policies          HTML     47K 
                (Details Narrative)                                              
46: R32         Investments (Details)                               HTML     40K 
47: R33         Investments (Details 1)                             HTML     34K 
48: R34         Investments (Details Narrative)                     HTML     24K 
49: R35         Patents and Licenses (Details)                      HTML     26K 
50: R36         Patents and Licenses (Details 1)                    HTML     31K 
51: R37         Patents and Licenses (Details Narrative)            HTML     22K 
52: R38         Line of Credit (Details Narrative)                  HTML     23K 
53: R39         Income Taxes (Details)                              HTML     38K 
54: R40         Income Taxes (Details 1)                            HTML     43K 
55: R41         Income Taxes (Details 2)                            HTML     40K 
56: R42         Income Taxes (Details 3)                            HTML     29K 
57: R43         Income Taxes (Details Narrative)                    HTML     27K 
58: R44         Stockholders Equity (Details Narrative)             HTML     31K 
59: R45         Income Per Share (Details)                          HTML     53K 
60: R46         Income Per Share (Details Narrative)                HTML     21K 
61: R47         Stockbased Compensation (Details)                   HTML     52K 
62: R48         Stockbased Compensation (Details 1)                 HTML     33K 
63: R49         Stockbased Compensation (Details 2)                 HTML     40K 
64: R50         Stockbased Compensation (Details 3)                 HTML     35K 
65: R51         Stockbased Compensation (Details Narrative)         HTML     63K 
66: R52         Industry Segment and Geographic Information         HTML     20K 
                (Details Narrative)                                              
67: R53         Employee Retirement and Benefit Plans (Details      HTML     23K 
                Narrative)                                                       
68: R54         Commitment and contingencies (Details Narrative)    HTML     26K 
71: XML         IDEA XML File -- Filing Summary                      XML    123K 
69: XML         XBRL Instance -- atri_10k_htm                        XML   1.19M 
70: EXCEL       IDEA Workbook of Financial Reports                  XLSX     77K 
12: EX-101.CAL  XBRL Calculations -- atri-20211231_cal               XML    118K 
14: EX-101.DEF  XBRL Definitions -- atri-20211231_def                XML    294K 
11: EX-101.LAB  XBRL Labels -- atri-20211231_lab                     XML    808K 
13: EX-101.PRE  XBRL Presentations -- atri-20211231_pre              XML    630K 
10: EX-101.SCH  XBRL Schema -- atri-20211231                         XSD    140K 
72: JSON        XBRL Instance as JSON Data -- MetaLinks              313±   414K 
73: ZIP         XBRL Zipped Folder -- 0001654954-22-002094-xbrl      Zip    173K 


‘EX-23’   —   Consent of Expert or Counsel


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

EXHIBIT 23

 

Consent of Independent Registered Public Accounting Firm

 

We have issued our reports dated February 25, 2022, with respect to the consolidated financial statements and internal control over financial reporting included in the Annual Report of Atrion Corporation on Form 10-K for the year ended December 31, 2021. We consent to the incorporation by reference of said reports in the Registration Statements of Atrion Corporation on Forms S-8 (File No. 333-142917, effective May 14, 2007, File No.  333-144085, effective June 27, 2007, File No.  333-144086 effective June 27, 2007, File No. 333-172767, effective March 11, 2011 and File No 333-256352 effective May 21, 2021).

 

/s/ GRANT THORNTON LLP

 

Dallas, Texas

 

February 25, 2022


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-K’ Filing    Date    Other Filings
Filed on:2/25/228-K
For Period end:12/31/21SD
5/21/214,  4/A,  8-K,  DEF 14A,  S-8
3/11/1110-K,  S-8
6/27/07S-8
5/14/07S-8
 List all Filings 


1 Subsequent Filing that References this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/27/23  Atrion Corp.                      10-K       12/31/22   72:5.2M                                   Blueprint/FA


19 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/08/21  Atrion Corp.                      10-Q        9/30/21   46:2.8M                                   Blueprint/FA
 8/09/21  Atrion Corp.                      10-Q        6/30/21   46:2.8M                                   Blueprint/FA
 4/07/21  Atrion Corp.                      DEF 14A     5/21/21    1:1M                                     Toppan Merrill/FA
 3/01/21  Atrion Corp.                      10-K       12/31/20   77:5.2M                                   Blueprint/FA
 5/09/18  Atrion Corp.                      10-Q        3/31/18   44:2M                                     Blueprint/FA
 3/19/18  Atrion Corp.                      8-K:1,5,9   3/13/18    3:192K                                   Toppan Merrill/FA
11/08/17  Atrion Corp.                      10-Q        9/30/17   41:2M                                     Blueprint/FA
 3/03/17  Atrion Corp.                      8-K:1,2,9   2/28/17    4:755K                                   Toppan Merrill/FA
 5/25/16  Atrion Corp.                      8-K:1,5,9   5/24/16    2:37K                                    Toppan Vite NY Inc./FA
10/31/14  Atrion Corp.                      10-Q       10/27/14   36:1.5M                                   Issuer Direct/FA
 3/12/12  Atrion Corp.                      10-K       12/31/11   39:4.2M                                   Business Wire/FA
 8/04/11  Atrion Corp.                      10-Q        6/30/11   31:1.8M                                   Business Wire/FA
 5/27/11  Atrion Corp.                      8-K:5,9     5/27/11    3:78K                                    Baker Donel… Caldwell/FA
 3/13/09  Atrion Corp.                      10-K       12/31/08    9:1.5M                                   Marketwired/FA
 6/27/07  Atrion Corp.                      S-8         6/27/07    1:145K                                   Baker Donel… Caldwell/FA
 6/27/07  Atrion Corp.                      S-8         6/27/07    1:128K                                   Baker Donel… Caldwell/FA
11/07/06  Atrion Corp.                      10-Q        9/30/06    6:100K                                   Business Wire/FA
 5/12/00  Atrion Corp.                      10-Q        3/31/00    4:28K                                    Toppan Merrill/FA
 1/10/97  Atrion Corp.                      DEFS14A     2/21/97    1:184K                                   Bowne of Atlanta Inc./FA
Top
Filing Submission 0001654954-22-002094   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., May 13, 4:42:07.2pm ET